Proceeds from the Series A funding will further advance Xilis' proprietary MOS technology, expand its AI-driven capabilities, fund clinical studies for diagnostic development, and validate the use of MOS technology with biopharma partners.

Company Information

Company Status

Private & Independent

Industry

Healthcare IT

Mailing Address

801 Capitola Dr. 12
Durham, NC 27713
USA

Phone

Undisclosed

Website

www.xilis.com

Email Address

[email protected]

Overview

Xilis is a Stanford PhD and a PhD from UNC Chapel Hill (both now Duke University professors focused on oncology and precision health) came together for this company out of their acute awareness that when someone is diagnosed with cancer, finding the right treatment frequently takes months and often comes with countless side effects.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Xiling Shen

Chief Financial Officer

Gary Yeung

Chief Medical Officer

David Hsu

Chief Operating Officer

Daniel Delubac

Chief Scientific Officer

Hans Clevers

VP - Bus. Development

Stan Skrzypczak

Browse more venture capital transactions:

Prev: 7/9/2021: Meati Foods venture capital transaction
Next: 7/9/2021: NFT Oasis venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary